Physician profile
Maria Munoz
NPI 1407266901
$2,143.38
in general payments reported to CMS, 2019-2025
23 companies · $567 in 2025
The $567 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $249 · 2021: $32.77 · 2022: $57.38 · 2023: $470 · 2024: $381 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $642.51 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $250.11 | 2019-2023 | |
| Pfizer INC. | $183.54 | 2020-2024 | |
| Penumbra, INC. | $158.48 | 2025 | Indigo System |
| Acera Surgical, INC. | $151.56 | 2025 | Restrata Wound Matrix |
| Novo Nordisk INC | $114.33 | 2023 | Wegovy |
| Amag Pharmaceuticals, INC. | $63.88 | 2019-2020 | |
| Astellas Pharma US INC | $63.55 | 2020-2024 | Veozah |
| Millicent US INC | $63.09 | 2019-2025 | Intrarosa, Femring |
| Therapeuticsmd, INC. | $60.95 | 2019 | |
| Hologic Sales and Service, LLC | $59.74 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $54.83 | 2019-2024 | Slynd |
| Ge Healthcare | $45.68 | 2024 | |
| Aveo Pharmaceuticals, INC. | $42.02 | 2025 | |
| Urovant Sciences INC | $38.74 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $38.45 | 2023-2025 | Myfembree |
| Organon LLC | $24.49 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.03 | 2025 | |
| Avion Pharmaceuticals | $14.94 | 2019 | |
| Medtronic, INC. | $14.07 | 2023 | Closurefast |
| Biogen, INC. | $14.04 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $13.98 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.